Tag Archives: U.S.

AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle

AbbVie’s strength has long been tied to the performance of megablockbuster Humira, which is facing an existential threat as U.S. copycats creep closer. Despite a “more aggressive” than expected biosimilar challenge abroad, AbbVie believes its defense strategy—and lessons learned—will help it weather the storm. In an earnings call with analysts Friday, AbbVie CEO Rick Gonzalez touted the drugmaker’s… Read More »

Walmart to stop sales of e-cigarettes in U.S. stores: company memo

WASHINGTON (Reuters) – Walmart Inc (WMT.N) told staff on Friday it will stop selling e-cigarettes and electronic nicotine delivery products at its U.S. stores, amid a growing crackdown on surging teenage use of such products, reports of vaping-related lung disease and some deaths. FILE PHOTO: Walmart’s logo is seen outside one of the stores in… Read More »

Early Bird, an Internal Bleeding Detector, Now Available In U.S.

September 18th, 2019 Medgadget Editors Cardiac Surgery, Cardiology, Radiology, Vascular Surgery Saranas, a Houston, Texas firm, is releasing its novel Early Bird bleeding monitoring system in the United States, following FDA de novo approval of the device. Intended for use during minimally invasive vascular procedures, the Early Bird helps to identify dangerous events such as… Read More »

Can psychedelics treat anorexia, depression? U.S. scientists get millions to find out

Since childhood, Rachael Petersen had lived with an unexplainable sense of grief that no drug or talk therapy could entirely ease. So in 2017 she volunteered for a small clinical trial at Johns Hopkins University that was testing psilocybin, the active ingredient in magic mushrooms, for chronic depression. “I was so depressed,” Petersen, 29, said… Read More »